HCN updates MDref, fixes PracSoft bug

Health Communication Network (HCN) has released its February 2012 update of the MDref Drug Database.

It has also resolved a bug in its recent update of PracSoft, which was compromising demographic data in the practice management system. A new version of the update is now available through the HCN website and automatic updates.

The MDref update is current from February 1 and is a differential update that builds on the most recent full build of MDref in December 2011.

The update contains new information on the updated formula for the seasonal flu vaccine Influvac and a new strength for Influvac Junior.

It also includes information on Jevtana (cabazitaxel), which was approved by the Therapeutic Goods Administration (TGA) for the treatment, in combination with prednisone or prednisolone, of patients with hormone-refractory metastatic prostate cancer.

There are also new drug monographs and Product Information (PIs) on Trajenta (linagliptin), a dipeptidyl peptidase 4 inhibitor for adult patients with type 2 diabetes to improve glycaemic control, and Vimovo (naproxen and esomeprazole) for patients using NSAIDS for the symptomatic management of rheumatoid and osteoarthritis who have an increased risk of gastrointestinal ulceration.

The February 2012 MDref update for Medical Director users will be delivered via HCN's automatic update. Alternatively, users can download the update manually.

Posted in Australian eHealth

You need to log in to post comments. If you don't have a Pulse+IT website account, click here to subscribe.

Sign up for Pulse+IT eNewsletters

Sign up for Pulse+IT website access

For more information, click here.

Copyright © 2017 Pulse+IT Magazine
No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher.